Development of chondrosarcoma animal models for assessment of adjuvant therapy

ANZ Journal of Surgery

Volumn 79, Issue 5, 2009, Pages 327-336

  Clark, J C M ^a   Dass, C R ^a,c   Choong, P F M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Chondrosarcoma; Intratibial; Orthotopic; Xenograft

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; ANGIOGENESIS INHIBITOR; DEXAMETHASONE; RECOMBINANT CHONDROMODULIN; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; CANCER CELL CULTURE; CHONDROSARCOMA; EXPERIMENTAL MODEL; HAMSTER; HUMAN; HUMAN CELL CULTURE; MEDLINE; METASTASIS; NONHUMAN; REVIEW; TUMOR GROWTH;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CHONDROSARCOMA; COMBINED MODALITY THERAPY; CRICETINAE; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RATS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67650859912     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2009.04884.x     Document Type: Review

References (69)

1. Björnsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Primary chondrosarcoma of long bones and limb girdles. Cancer 1998 83 : 2105 19.
2. Lee FY, Mankin HJ, Fondren G et al. Chondrosarcoma of bone: an assessment of outcome. J. Bone Joint Surg. Am. 1999 81 : 326 38.
3. Bruns J, Elbracht M, Niggemeyer O. Chondrosarcoma of bone: an oncological and functional follow-up study. Ann. Oncol. 2001 12 : 859 64.
4. Pring ME, Weber KL, Unni KK, Sim FH. Chondrosarcoma of the pelvis. A review of sixty-four cases. J. Bone Joint Surg. Am. 2001 83-A : 1630 42.
5. Kim DW, Seo SW, Cho SK et al. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells. J. Orthop. Res. 2007 25 : 820 8.
6. Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma. J. Cancer Res. Clin. Oncol. 1999 125 : 541 8.
7. Burbridge MF, Cogé F, Galizzi JP, Boutin JA, West DC, Tucker GC. The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis 2002 5 : 215 26.
8. Yuan J, Dutton CM, Scully SP. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J. Orthop. Res. 2005 23 : 1467 74.
9. Klenke FM, Abdollahi A, Bertl E et al. Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo. BMC Cancer 2007 7 : 49.
10. Papachristou DJ, Papavassiliou AG. Osteosarcoma and chondrosarcoma: new signaling pathways as targets for novel therapeutic interventions. Int. J. Biochem. Cell Biol. 2007 39 : 857 62.
11. Murphy JB. Heteroplastic tissue grafting effected through roentgen-ray lymphoid destruction. J. Am. Med. Assoc. 1914 62 : 1459.
12. Toolan HW. Permanently transplantable human tumors maintained in conditioned heterologous hosts: H. Chon. #1, H. Ep. #4, and H. Ad. #1. Cancer Res. 1957 17 : 418 20.
13. Maibenco HC, Krehbiel RH, Nelson D. Transplantable osteogenic tumor in the rat. Cancer Res. 1967 27 : 362 6.
14. Flanagan SP. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet. Res. 1966 8 : 295 309.
15. Pantelouris EM. Absence of thymus in a mouse mutant. Nature 1968 217 : 370 1.
16. Giovanella BC, Stehlin JS, Williams LJ Jr. Heterotransplantation of human malignant tumors in 'nude' thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors. J. Natl. Cancer Inst. 1974 52 : 921 30.
17. Fogh J, Fogh JM, Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 1977 59 : 221 6.
18. Azar HA, Hansen CT, Costa J. N NIH(S)-nu/nu mice with combined immunodeficiency: a new model for human tumor heterotransplantation. J. Natl. Cancer Inst. 1980 65 : 421 30.
19. Kawashima H, Ogose A, Hayami T et al. Effect of dexamethasone on growth inhibition and chondrogenic maturation of human chondrosarcoma. J. Orthop. Sci. 2003 8 : 341 5.
20. Choi HU, Meyer K, Swarm R. Mucopolysaccharide and protein - polysaccharide of a transplantable rat chondrosarcoma. Proc. Natl. Acad. Sci USA 1971 68 : 877 9.
21. Breitkreutz D, de Leon D, Paglia L et al. Histological and biochemical studies of a transplantable rat chondrosarcoma. Cancer Res. 1979 39 : 5093 100.
22. Grimaud E, Damiens C, Rousselle AV, Passuti N, Heymann D, Gouin F. Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma. Histol. Histopathol. 2002 17 : 1103 11.
23. Kenan S, Steiner GC. Experimental transplantation of the Swarm rat chondrosarcoma into bone: radiological and pathological studies. J. Orthop. Res. 1991 9 : 445 51.
24. Stevens JW. Heterogeneity in growth properties of the rat Swarm chondrosarcoma. Iowa Orthop J. 2004 24 : 33 5.
25. Stevens JW, Patil SR, Jordan DK, Kimura JH, Morcuende JA. Cytogenetics of swarm rat chondrosarcoma. Iowa Orthop. J. 2005 25 : 135 40.
26. Mason RM, Bansal MK. Different growth rates of swarm chondrosarcoma in Lewis and Wistar rats correlate with different thyroid hormone levels. Connect Tissue Res. 1987 16 : 177 85.
27. McCumbee WD, McCarty KS Jr., Lebovitz HE. Hormone responsiveness of a transplantable rat chondrosarcoma. II. Evidence for in vivo hormone dependence. Endocrinology. 1980 106 : 1930 40.
28. Salomon DS, Paglia LM, Verbruggen L. Hormone-dependent growth of a rat chondrosarcoma in vivo. Cancer Res. 1979 39 : 4387 95.
29. Miller GJ, DeMarzo AM. Ultrastructural localization of matrix vesicles and alkaline phosphatase in the Swarm rat chondrosarcoma: their role in cartilage calcification. Bone 1988 9 : 235 41.
30. Taylor DO. Transplantable chondrosarcoma in the Syrian hamster (Mesocricetus auratus). Cancer Res. 1968 28 : 2051 5.
31. Fujisawa N, Sato NL, Motoyama T. Establishment of clonal cell lines, with or without cartilage phenotypes, from a hamster mesenchymal chondrosarcoma. Lab. Anim. Sci. 1991 41 : 590 5.
32. Fujisawa N, Sato NL, Motoyama TI. Inhibitory effects of transforming growth factor-beta1 pretreatment on experimental pulmonary metastasis of MCS-1 Chinese hamster mesenchymal chondrosarcoma cells. Tohoku J. Exp. Med. 1999 187 : 203 13.
33. Becher OJ, Holland EC. Genetically engineered models have advantages over xenografts for preclinical studies. Cancer Res. 2006 66 : 3355 8, discussion 8 9.
34. Kunisada T, Miyazaki M, Mihara K et al. A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int. J. Cancer 1998 77 : 854 9.
35. Hayami T, Shukunami C, Mitsui K et al. Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett. 1999 458 : 436 40.
36. Furumatsu T, Nishida K, Kawai A, Namba M, Inoue H, Ninomiya Y. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth. Int. J. Cancer 2002 97 : 313 22.
37. Nishida K, Kunisada T, Shen ZN, Kadota Y, Hashizume K, Ozaki T. Chondrosarcoma and peroxisome proliferator-activated receptor. PPAR. Res. 2008 2008 : 250568.
38. Takigawa M, Tajima K, Pan HO et al. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res. 1989 49 : 3996 4002. (Pubitemid 19197434)
39. Takigawa M, Pan HO, Kinoshita A, Tajima K, Takano Y. Establishment from a human chondrosarcoma of a new immortal cell line with high tumorigenicity in vivo, which is able to form proteoglycan-rich cartilage-like nodules and to respond to insulin in vitro. Int. J. Cancer 1991 48 : 717 25.
40. Kudo N, Ogose A, Hotta T et al. Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation. Virchows Arch. 2007 451 : 691 9.
41. Oshiro Y, Chaturvedi V, Hayden D et al. Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study. Cancer 1998 83 : 2324 34.
42. Kudawara I, Araki N, Myoui A, Kato Y, Uchida A, Yoshikawa H. New cell lines with chondrocytic phenotypes from human chondrosarcoma. Virchows Arch. 2004 444 : 577 86.
43. Klenke FM, Merkle T, Fellenberg J et al. A novel model for the investigation of orthotopically growing primary and secondary bone tumours using intravital microscopy. Lab. Anim. 2005 39 : 377 83.
44. Morioka H, Weissbach L, Vogel T et al. Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin. Cancer Res. 2003 9 : 1211 7.
45. Machado I, Giner F, Mayordomo E, Carda C, Navarro S, Llombart-Bosch A. Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study. Diagn. Pathol. 2008 3 (Suppl. 1 S25.
46. Greenspan A, Jundt G, Remagen W. Differential Diagnosis in Orthopaedic Oncology. Philadelphia, PA : Lippincott Williams and Wilkins, 2007.
47. Delloye C, Banse X, Brichard B, Docquier PL, Cornu O. Pelvic reconstruction with a structural pelvic allograft after resection of a malignant bone tumor. J. Bone Joint Surg. Am. 2007 89 : 579 87.
48. Herwig J, Roessner A, Buddecke E. Isolation and characterization of proteoglycans and glycosaminoglycans from human chondrosarcoma. Exp. Mol. Pathol. 1986 45 : 118 27.
49. Schörle CM, Finger F, Zien A, Block JA, Gebhard PM, Aigner T. Phenotypic characterization of chondrosarcoma-derived cell lines. Cancer Lett. 2005 226 : 143 54.
50. Elima K, Vuorio E. Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett. 1989 258 : 195 8.
51. Aigner T, Müller S, Neureiter D, Illstrup DM, Kirchner T, Björnsson J. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas. Cancer 2002 94 : 2273 81.
52. Dass CR, Ek ET, Choong PF. Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing. J. Cancer Res. Clin. Oncol 2007 133 : 193 8.
53. Walkley CR, Qudsi R, Sankaran VG et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev. 2008 22 : 1662 76.
54. Miller CW, Aslo A, Tsay C et al. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res. 1990 50 : 7950 4.
55. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995 75 : 2186 95.
56. Rüther U, Komitowski D, Schubert FR, Wagner EF. c-fos expression induces bone tumors In transgenic mice. Oncogene 1989 4 : 861 5.
57. Weisstein JS, Majeska RJ, Klein MJ, Einhorn TA. Detection of c-fos expression in benign and malignant musculoskeletal lesions. J. Orthop Res. 2001 19 : 339 45.
58. Tsuneyoshi M, Enjoji M, Iwasaki H, Shinohara N. Extraskeletal myxoid chondrosarcoma - a clinicopathologic and electron microscopic study. Acta Pathol. Jpn. 1981 31 : 439 47.
59. Ozaki T, Hillmann A, Linder N, Blasius S, Winkelmann W. Metastasis of chondrosarcoma. J. Cancer Res. Clin. Oncol. 1996 122 : 629 32.
60. Gregson RL, Offer JM. Metastasizing chondrosarcoma in laboratory rats. J. Comp. Pathol. 1981 91 : 409 13.
61. Sanerkin NG, Gallagher P. A review of the behaviour of chondrosarcoma of bone. J. Bone Joint Surg. Br. 1979 61-B : 395 400. (Pubitemid 10201796)
62. Hoffman RM. Green fluorescent protein to visualize cancer progression and metastasis. Methods Enzymol. 1999 302 : 20 31. (Pubitemid 29180720)
63. Dass CR, Choong PF. GFP expression alters osteosarcoma cell biology. DNA Cell Biol. 2007 26 : 599 601. (Pubitemid 47263206)
64. Li XF, Zanzonico P, Ling CC, O'Donoghue J. Visualization of experimental lung and bone metastases in live nude mice by X-ray micro-computed tomography. Technol. Cancer Res. Treat. 2006 5 : 147 55.
65. Sharkey RM, Karacay H, Vallabhajosula S et al. Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model. Radiology. 2008 246 : 497 507.
66. Dass CR, Ek ET, Contreras KG, Choong PF. A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin. Exp. Metastasis 2006 23 : 367 80.
67. Ek ET, Dass CR, Contreras KG, Choong PF. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Ther. 2007 14 : 616 26.
68. Dass CR, Choong PF. uPAR mediates anticancer activity of PEDF. Cancer Biol. Ther. 2008 7 : 1262 70.
69. Dass CR, Khachigian LM, Choong PF. c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model. Mol. Cancer Res. 2008 6 : 1289 92.